Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Biotech & Pharma Whining About Talent: That Makes Me Mad 02/18/13 National
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Join Us Oct. 16 for ‘Reinventing Biotech’s Business Model’ in SF 09/11/12 San Francisco
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
OncoGenex Snags $50M for Prostate Cancer Drug Plan 03/16/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech 02/27/12 National
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Exelixis To Push Ahead on Prostate Cancer Trial Without FDA Agreement: Shares Plunge 10/31/11 San Francisco
Exelixis Passes Key Test With Lead Drug; Stock Soars 10/24/11 San Francisco
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity 09/12/11 National
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials 07/18/11 San Diego
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Page 1 of 3 next page »